{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T21:06:22Z","timestamp":1781298382858,"version":"3.54.1"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>To prevent inflammatory side effects early in the titration phase of clozapine, international guidelines recommend measuring clozapine blood levels weekly. However, data on such measurements are lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We retrospectively reviewed the medical records of all patients with schizophrenia who were treated with clozapine for the first time and whose clozapine blood levels were measured for at least 2 consecutive weeks from clozapine initiation at our institution from 2020 to 2024. Patients were divided into 2 groups based on whether they had a fever during the first 6\u2009weeks of clozapine treatment. The clozapine concentration-to-dose (C\/D) ratios were compared weekly within 6\u2009weeks after starting clozapine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 28 patients were included in the study, of whom 6 developed a fever and 22 did not. The median C\/D ratios in weeks 1 and 2 were significantly higher in patients with a fever than in those without (week 1: 2.12 vs 1.31,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u20090.0217; week 2: 3.48 vs 1.23,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u20090.01). There was no significant difference in C\/D ratios between the groups from week 3 to week 6. During the first 6\u2009weeks of treatment, C\/D ratios increased markedly and showed peaks in patients with fever but remained stable in patients without fever.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Measuring clozapine blood levels early in the titration phase helps estimate the metabolic capacity of patients. Furthermore, it is essential to pay attention to inflammation, which may increase clozapine C\/D ratios.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/jcp.0000000000002003","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T21:39:50Z","timestamp":1743802790000},"page":"345-348","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Weekly Changes in the Clozapine Concentration-to-Dose Ratio During Clozapine Titration in Japanese Patients With Schizophrenia"],"prefix":"10.1097","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1184-8918","authenticated-orcid":false,"given":"Yuki","family":"Kikuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutsumi","family":"Sakata","sequence":"additional","affiliation":[{"name":"Nozoe Hills Hospital, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuro","family":"Ikawa","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacotherapy, Hiroshima University, Hiroshima"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Kume","sequence":"additional","affiliation":[{"name":"Nozoe Hills Hospital, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Horikawa","sequence":"additional","affiliation":[{"name":"Nozoe Hills Hospital, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Komatsu","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Tohoku University Hospital, Sendai Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"key":"bib1-20260219","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2019.07.040","article-title":"Clinical determinants of fever in clozapine users and implications for treatment management: a narrative review","volume":"211","author":"Verdoux","year":"2019","journal-title":"Schizophr Res"},{"key":"bib2-20260219","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1055\/a-1625-6388","article-title":"An international adult guideline for making clozapine titration safer by using six ancestry-based personalized dosing titrations, CRP, and clozapine levels","volume":"55","author":"de Leon","year":"2022","journal-title":"Pharmacopsychiatry"},{"key":"bib3-20260219","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.schres.2023.09.029","article-title":"Association between initial pattern of clozapine titration, concentration-to-dose ratio, and incidence of fever in patients with schizophrenia spectrum disorders in a Korean tertiary hospital","volume":"268","author":"Kang","year":"2024","journal-title":"Schizophr Res"},{"key":"bib4-20260219","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0378-4347(98)00202-3","article-title":"Determination of clozapine, desmethylclozapine and clozapine N-oxide in human plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection","volume":"714","author":"Avenoso","year":"1998","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"bib5-20260219","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.psym.2019.08.008","article-title":"Rapid titration and decreased clozapine clearance may help explain five cases of clozapine-induced myocarditis in a New York hospital","volume":"61","author":"de Leon","year":"2020","journal-title":"Psychosomatics"},{"key":"bib6-20260219","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.rpsm.2021.10.003","article-title":"Valproate, obesity and other causes of clozapine poor metabolism in the context of rapid titration may explain clozapine-induced myocarditis: a re-analysis of a Turkish case series","volume":"15","author":"Ertu\u011frul","year":"2022","journal-title":"Rev Psiquiatr Salud Ment (Engl Ed)"},{"key":"bib7-20260219","first-page":"29","article-title":"Four cases of myocarditis in US hospitals possibly associated with clozapine poor metabolism and a comparison with prior published cases","volume":"24","author":"Koenig","year":"2022","journal-title":"Neuropsychopharmacol Hung"},{"key":"bib8-20260219","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/JCP.0000000000001202","article-title":"Adding oral contraceptives to clozapine may require halving the clozapine dose: a new case and a literature review","volume":"40","author":"Schoretsanitis","year":"2020","journal-title":"J Clin Psychopharmacol"},{"key":"bib9-20260219","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.schres.2017.03.045","article-title":"Elevated clozapine levels associated with infection: a systematic review","volume":"192","author":"Clark","year":"2018","journal-title":"Schizophr Res"},{"key":"bib10-20260219","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1503\/jpn.200061","article-title":"Consensus statement on the use of clozapine during the COVID-19 pandemic","volume":"45","author":"Siskind","year":"2020","journal-title":"J Psychiatry Neurosci"},{"key":"bib11-20260219","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3109\/00048674.2011.572852","article-title":"A new monitoring protocol for clozapine-induced myocarditis based on an analysis of 75 cases and 94 controls","volume":"45","author":"Ronaldson","year":"2011","journal-title":"Aust N Z J Psychiatry"},{"key":"bib12-20260219","doi-asserted-by":"crossref","first-page":"1366621","DOI":"10.3389\/fpsyt.2024.1366621","article-title":"Patterns of C-reactive protein trends during clozapine titration and the onset of clozapine-induced inflammation: a case series of weekly and daily C-reactive protein monitoring","volume":"15","author":"Kikuchi","year":"2024","journal-title":"Front Psychiatry"},{"key":"bib13-20260219","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.2147\/NDT.S473973","article-title":"Effect of common cold on serum clozapine concentrations in hospitalized patients with schizophrenia","volume":"20","author":"Cao","year":"2024","journal-title":"Neuropsychiatr Dis Treat"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JCP.0000000000002003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T15:01:05Z","timestamp":1771513265000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JCP.0000000000002003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0000000000002003","relation":{},"ISSN":["1533-712X","0271-0749"],"issn-type":[{"value":"1533-712X","type":"electronic"},{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,7]]}}}